Warberg Asset Management’s NeuroSense Therapeutics NRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,700	Closed	-$9.95K	–	184
2025 Q1	$9.95K	Hold	10,700	–	–	﹤0.01%	129
2024 Q4	$12.8K	Buy	+10,700	New	+$12.8K	﹤0.01%	130
2022 Q1	–	Sell	-15,501	Closed	-$38K	–	229
2021 Q4	$38K	Buy	+15,501	New	+$38K	0.01%	129